The effect of statins through mast cells in the pathophysiology of atherosclerosis: a review
H Kouhpeikar, Z Delbari, T Sathyapalan… - Current Atherosclerosis …, 2020 - Springer
Abstract Purpose of Review In this review, we discuss the evidence supporting the effects of
statins on mast cells (MCs) in atherosclerosis and their molecular mechanism of action …
statins on mast cells (MCs) in atherosclerosis and their molecular mechanism of action …
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases
M Lai, H Peng, X Wu, X Chen, B Wang, X Su - International …, 2022 - Elsevier
Hyperlipidemia is confirmed to be associated with several health problems that include the
combination of diabetes mellitus, obesity, and hypertension, ie, metabolic syndrome …
combination of diabetes mellitus, obesity, and hypertension, ie, metabolic syndrome …
Interleukin-22: a potential therapeutic target in atherosclerosis
JW Luo, Y Hu, J Liu, H Yang, P Huang - Molecular medicine, 2021 - Springer
Background Atherosclerosis is recognized as a chronic immuno-inflammatory disease that is
characterized by the accumulation of immune cells and lipids in the vascular wall. In this …
characterized by the accumulation of immune cells and lipids in the vascular wall. In this …
The elevated expression of IL-38 serves as an anti-inflammatory factor in osteoarthritis and its protective effect in osteoarthritic chondrocytes
L Jiang, X Zhou, C Huang, J Bao, J Li, K Xu… - International …, 2021 - Elsevier
The objective of this study is to investigate the role of IL-38 in osteoarthritis (OA). IL-38 levels
in serum and synovial fluid (SF) of patients with OA were examined to identify the correlation …
in serum and synovial fluid (SF) of patients with OA were examined to identify the correlation …
Immunobiological properties and clinical applications of interleukin-38 for immune-mediated disorders: a systematic review study
A Esmaeilzadeh, N Bahmaie, E Nouri… - International Journal of …, 2021 - mdpi.com
Exponential growth in the usage of “cytokines”(as seroimmunobiomarkers) has facilitated
more accurate prognosis, early diagnosis, novel, and efficient immunotherapeutics …
more accurate prognosis, early diagnosis, novel, and efficient immunotherapeutics …
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Y Xue, M Chen, Q Chen, T Huang, Q Fan, F Lin, J Ke… - Virology Journal, 2021 - Springer
Abstract Background Interleukin (IL)-38, a novel member of the IL-1 family, has been
reported to be involved in several diseases associated with viral infection. However, the …
reported to be involved in several diseases associated with viral infection. However, the …
Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases
Y Gao, L Cai, Y Wu, M Jiang, Y Zhang… - CNS Neuroscience …, 2024 - Wiley Online Library
Abstract Interleukin (IL)‐38 is a newly discovered cytokine of the IL‐1 family, which binds
various receptors (ie, IL‐36R, IL‐1 receptor accessory protein‐like 1, and IL‐1R1) in the …
various receptors (ie, IL‐36R, IL‐1 receptor accessory protein‐like 1, and IL‐1R1) in the …
Cross-Talk of Atherosclerosis and Ischemic Stroke: Dramatic Role of Neutrophils
A Esmaeilzadeh, M Zarerafie… - Archives of …, 2021 - brieflands.com
Context: Current investigations illustrate the increasing prevalence of atherosclerosis (AS)
through the aggravating role of inappropriate lifestyle patterns. Atherosclerosis is the cause …
through the aggravating role of inappropriate lifestyle patterns. Atherosclerosis is the cause …
[HTML][HTML] Интерлейкин-38 и сердечно-сосудистая патология: обзор литературы
АМ Алиева, ИЕ Байкова, ТВ Пинчук… - …, 2023 - cyberleninka.ru
Кардиоваскулярная патология—основная причина заболеваемости и смертности
населения во всём мире. Важной задачей современной кардиологии является поиск и …
населения во всём мире. Важной задачей современной кардиологии является поиск и …
Clinical applications of interleukin-37; as a key player in the immunopathogenesis of immune disorders
Recently, the era of medicine has been encountered with the exponential growth of special
seroimmunobiomarkers in clinical trials. Lately, Interleukin-37 (IL-37) has attracted a wide …
seroimmunobiomarkers in clinical trials. Lately, Interleukin-37 (IL-37) has attracted a wide …